BofA Securities on Merck (MRK): Terns adds to 2025 deals for de-risked drugs 'with growth expected during Keytrude LOE period'
Go back to BofA Securities on Merck (MRK): Terns adds to 2025 deals for de-risked drugs 'with growth expected during Keytrude LOE period'| Merck & Co. (NYSE: MRK) | Delayed: 119.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $119.60 | 52 Week High | $65.46 | |||
| Open | $119.60 | 52 Week Low | $47.97 | |||
| Day High | $119.60 | P/E | 81.36 | |||
| Day Low | $119.60 | EPS | $1.47 | |||
| Volume | 1,113 | |||||
